References
- Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031–41.
- Simmons Z, Felgoise SH, Bremer BA, Walsh SM, Hufford DJ, Bromberg MB, . The ALSSQoL: balancing physical and non-physical factors in assessing quality of life in ALS. Neurology. 2006;67:1659–64.
- Hammer EM, Hacker S, Hautzinger M, Meyer TD, Kubler A. Validity of the ALS Depression Inventory (ADI-12) − a new screening instrument for depressive disorders in patients with amyotrophic lateral sclerosis. J Affect Disord. 2008;109:213–9.
- Millecamps S, Salachas F, Cazeneuve C, Gordon P, Bricka B, Camuzat A, . SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet. 2010;47:554–60.
- Beghi E, Mennini T, Bendotti C, Bigini P, Logroscino G, Chio A, . The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure. Curr Med Chem. 2007;14:3185–200.
- Pagnini F, Rossi G, Lunetta C, Banfi P, Corbo M. Clinical psychology and amyotrophic lateral sclerosis. Front Psychol. 2010;30:5.